Journal article
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Abstract
Treatment of chronic graft-versus-host disease is intended to produce a sustainable benefit by reducing symptom burden, controlling objective manifestations of disease activity, preventing damage and impairment, and improving overall survival without causing disproportionate harms related to the treatment itself. Successful management can control the disease until systemic treatment is no longer needed. The complexity of the disease, the …
Authors
Martin PJ; Lee SJ; Przepiorka D; Horowitz MM; Koreth J; Vogelsang GB; Walker I; Carpenter PA; Griffith LM; Akpek G
Journal
Transplantation and Cellular Therapy, Vol. 21, No. 8, pp. 1343–1359
Publisher
Elsevier
Publication Date
8 2015
DOI
10.1016/j.bbmt.2015.05.004
ISSN
2666-6367